The Red Cell Component (lect 2) Flashcards
LRBC
leukoreduced rbcs
Transfusion therapy
risk and benefits
risks: rejection, exposure to pathogens, cllinical repercussions
Benefits: blood oxy content, iron, hemostasis, cardiac output
Blood Component preparation
things made from whole blood
rbcs
granulocytes
plts
plasma
cryo
clot factor derives
rhogam
igs
antisera
alb
Whole blood statistics
vol
storage
shelf life
HCT
fibrinogen
vol - 450-500ml
Storage 2-6 c
Shelf life 21 days CPD
HCT - 38%
Fibrino - 1000mg
Whole blood is used for…
risks? (autologous units?)
MUST?
volume expansion and oxygen capacity
“autologous units”
Risk of circulatory overload
MUST match forwards and reverse
In order to collect and process blood, a facility must submit to ?
FDA inspection
PLT (deciding to use whole blood for plts)
Cool to RT
20-24 c within 24hr
Plasma (deciding to use from whole blood)
cool to 1-10c within 8hr
Whole blood from apheresis
what distinguishes it from regular procedure?
intermitten and continous flow distinguish from regular procedure
Deferral requirements for donors
40% HCT 16 wk deferral
Risks of apheresis whole blood donation
citrate toxicity
vascular access
vasovageal rxns
Clinical treatment of whole blood
Plasmapheresis
Photophoresis
Erythrophoresis
Plasma - warm auto
Photo - leukemia
Erythro - sickle cells
ISBT label
Donor, expiration, description..etc
E-CODE- what type of product this is and what has happened to it
Leukocyte reduced/packed rbcs
LRBC/PRBC
stats
Vol
Hct
shelf life
temp
Reduced: <5 x 103 wbc count
Vol: 250-300ml (apheresis vol exact is listed)
Hct: 60-85% (<80 desirable)
Shelf life 21-42 days
TEMP 2-6 degrees
LRBC/PRBC used for
Expected outcome
Risks
most common rbc component
(reduced HLA exposure/fever)
Expected: incr hgb 1g/dL or HCT 3% 24hr after completion
risk: graft vs host: patho exposure